Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Aug 24 | MORF Morphic Holding | Common Stock | Sale back to company | Dispose D | No | No | 0 | 2,376 | 0.00 | 0 |
16 Aug 24 | MORF Morphic Holding | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 30.52 | 23,168 | 707.09 k | 0 |
16 Aug 24 | MORF Morphic Holding | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 56.47 | 12,535 | 707.85 k | 0 |
16 Aug 24 | MORF Morphic Holding | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 24.49 | 17,550 | 429.80 k | 0 |
16 Aug 24 | MORF Morphic Holding | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 64.79 | 9,996 | 647.64 k | 0 |
16 Aug 24 | MORF Morphic Holding | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 31 | 24,000 | 744.00 k | 0 |
18 Jun 24 | INZY Inozyme Pharma | Stock Option Common Stock | Grant | Acquire A | No | No | 4.4 | 28,000 | 123.20 k | 28,000 |
4 Jun 24 | MORF Morphic Holding | Common Stock Common Stock | Grant | Acquire A | No | No | 30.52 | 23,168 | 707.09 k | 23,168 |
29 Apr 24 | VRNA Verona Pharma | Share Options Ordinary Shares | Grant | Acquire A | No | No | 1.9338 | 240,000 | 464.11 k | 240,000 |
20 Nov 23 | VRNA Verona Pharma | Ordinary Shares | Buy | Acquire P | No | No | 1.837 | 33,736 | 61.97 k | 144,800 |